XENOTRANSPLANTATION SUBCOMMITTEE
of the
BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE
January 13, 2000
Slides
Topic I Blood Donor Deferral
FDA Perspective, Dr. Andrew Dayton
Topic II Examination of Risks Posed by Different Types of Xenotransplantation Products
FDA Perspective, Dr. Eda Bloom